0001493152-23-009295.txt : 20230328
0001493152-23-009295.hdr.sgml : 20230328
20230328163658
ACCESSION NUMBER: 0001493152-23-009295
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230327
FILED AS OF DATE: 20230328
DATE AS OF CHANGE: 20230328
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Myers Jeff Lynn
CENTRAL INDEX KEY: 0001971112
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38892
FILM NUMBER: 23770103
MAIL ADDRESS:
STREET 1: C/O BEYOND AIR, INC.
STREET 2: 900 STEWART AVENUE, SUITE 301
CITY: GARDEN CITY
STATE: NY
ZIP: 11530
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Beyond Air, Inc.
CENTRAL INDEX KEY: 0001641631
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 473812456
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 825 EAST GATE BOULEVARD, SUITE 320
CITY: GARDEN CITY
STATE: NY
ZIP: 11530
BUSINESS PHONE: 516-665-8200
MAIL ADDRESS:
STREET 1: 825 EAST GATE BOULEVARD, SUITE 320
CITY: GARDEN CITY
STATE: NY
ZIP: 11530
FORMER COMPANY:
FORMER CONFORMED NAME: AIT Therapeutics, Inc.
DATE OF NAME CHANGE: 20170117
FORMER COMPANY:
FORMER CONFORMED NAME: KokiCare, Inc.
DATE OF NAME CHANGE: 20150507
4
1
ownership.xml
X0407
4
2023-03-27
0
0001641631
Beyond Air, Inc.
XAIR
0001971112
Myers Jeff Lynn
900 STEWART AVENUE,
SUITE 301
GARDEN CITY
NY
11530
0
1
0
0
Chief Medical Officer
0
Common Stock
2023-03-27
4
A
0
50000
0
A
50000
D
Stock Option (right to buy)
6.14
2023-03-27
4
A
0
50000
0
A
2033-03-26
Common Stock
50000
50000
D
Represents restricted stock units ("RSUs") granted on March 27, 2023 to acquire 50,000 shares of common stock of Beyond Air, Inc. (the "Issuer"). The RSUs will vest as to 20% of the shares of common stock underlying the RSUs on December 15, 2023, with the remainder vesting in equal annual installments on December 15 of each of the four ensuing years thereafter until vested in full, in each case subject to the reporting person's continued service with the Issuer. Each RSU represents the right to receive one share of common stock of the Issuer.
The option will vest as to 25% of the shares of common stock underlying the option on March 27, 2024, with the remainder vesting in equal annual installments on March 27 of each of the three ensuing years thereafter until vested in full, in each case subject to the reporting person's continued service with the Issuer.
/s/ Adam T. Newman, as attorney-in-fact
2023-03-28